Liraglutide
100% Online — No Office Visit Required
Liraglutide (brand name Saxenda) is an earlier GLP-1 receptor agonist with an established clinical track record for weight management. Requires daily injection vs. the weekly schedule of semaglutide.
What Is Liraglutide?
Liraglutide is a GLP-1 receptor agonist with a shorter half-life than semaglutide, requiring daily injections. It has been FDA-approved for obesity management under the brand name Saxenda since 2014.
How OakMD Works
OakMD is a telemedicine platform connecting eligible adults with licensed providers. If you're interested in Liraglutide, the process begins with a brief online intake form. A licensed provider will review your health history, symptoms, and goals — and determine if treatment is appropriate for you.
If you are a candidate, your provider will create a personalized treatment plan and guide you through next steps. There are no in-person visits required.
Common Questions
Is liraglutide as effective as semaglutide?
Generally, semaglutide shows greater weight loss in trials. Liraglutide has a longer track record and may be preferable for some patients based on individual response and provider recommendation.
Ready to Get Started?
Complete a brief online intake. A licensed provider will review your information and determine if treatment is appropriate for you.
Medical Disclaimer: The information on this page is provided for educational purposes only and does not constitute medical advice. OakMD is a telemedicine platform. All treatments are prescription-based, subject to provider review, and may not be appropriate for all individuals. A licensed provider will evaluate your medical history and determine eligibility. Consult a qualified healthcare professional before starting any new treatment.